Magnasense Press Releace

Investors

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

2023-05-29 19:03 AegirBio rapporterar icke-kassapåverkande kostnad efter nedskrivning av goodwill Regulatory MAR
2023-04-19 08:52 AEGIRBIO AB UTSER CHRISTEL DAHLBERG TILL INTERIM CFO Regulatory
2023-04-13 12:32 Finansinspektionen startar utredning av AegirBios hantering av insiderinformation Regulatory MAR
2023-03-31 17:43 Bokslutskommuniké 2022 Regulatory MAR
2023-03-23 11:14 AegirBio AB: Atlas Special Opportunities, LLC calls for partial conversion of outstanding convertible bonds to a nominal amount of MSEK 10.00 Regulatory MAR
2023-03-23 11:14 AegirBio AB: Atlas Special Opportunities, LLC påkallar partiell konvertering av utestående konvertibler till ett nominellt belopp om 10,00 MSEK Regulatory MAR
2023-03-14 08:39 The Disciplinary Committee of Nasdaq Stockholm has resolved that AegirBio shall pay fees Regulatory MAR
PreviousNext

Contact

For questions related to Investor Relations, please contact:

Email: ir@subgen.ai

Subscribe to our press releases

By clicking the Sign Up button, you agree to the privacy policy

en_USEN
en_USEN es_ESES
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.